Use access key #2 to skip to page content.
$2.35 0.00 (0.00%)
6/9/2008 4:00 PM

Encysive Pharmaceuticals, Inc. (ENCY.DL)

CAPS Rating:
No stars

A global biopharmaceutical company that engages in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs.

View All Commentary (ENCY.DL)

Recs

2

Avatar csmith201 (98.36) Submitted: 6/18/07 5:12 PM : Underperform Start Price: $2.30 ENCY.DL Score: -12.62

Rival biopharmaceutical company wins approval for it's drug while ENCYSIVE's drug will require more work before the FDA will approve it...This will cause the firm more money and possibly cause it to go bankrupt...

Report this Post Replies: 0 | Reply

Featured Broker Partners